뒤로
Mabpharm Limited(02181.HK) 가격
02181.HK 주가 차트
MABPHARM-B (02181.HK)
Mabpharm Limited
HK$0.52
4%
$0.02
장 종료: Jan 20, 16:00:00 HKT
주요 통계
이전 종가
$0.5
시가
$0.5
일일 범위
$0.5 - $0.52
52주 범위
$0.25 - $0.94
거래량
66.0K
평균 거래량
89.7K
EPS(TTM)
-0.01
배당수익률
--
시가총액
$2.1B
MABPHARM-B란 무엇인가요?
Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 383 full-time employees. The company went IPO on 2019-05-31. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The firm is also engaged in the transfer of intellectual property. The firm mainly conducts its business in the domestic market.